The real-world impact of corticosteroid-associated adverse events in myasthenia gravis: A patient-reported survey analysis
This study systematically assessed the incidence and risk factors of corticosteroid-related AEs in Chinese MG patients. The study found that the occurrence of AEs was associated with the cumulative dosage and duration of corticosteroid use. Additionally, long disease duration, a history of myasthenic crises, and an average daily dosage exceeding 5 mg/d are identified as risk factors for corticosteroid-related AEs in patients with MG.
Authors
- Peicai Fu (ORCID: https://orcid.org/0000-0002-1841-4186)
- Zhijun Li (ORCID: https://orcid.org/0009-0009-4250-3427)
- Mengcui Gui
- Kang‐Ho Choi (ORCID: https://orcid.org/0000-0001-8851-2104)
- Bitao Bu (ORCID: https://orcid.org/0000-0001-5369-7751)
- Mengge Yang (ORCID: https://orcid.org/0000-0001-7623-1022)
- Yue Li (ORCID: https://orcid.org/0000-0002-4279-2080)
- Jing Lin (ORCID: https://orcid.org/0009-0008-4916-7123)
- Jun Yan (ORCID: https://orcid.org/0000-0002-3261-0749)
Institutions
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Cellular Immunology
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1016/j.cellimm.2025.104956
- Citations
- 2
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- Innovative Research Group Project of the National Natural Science Foundation of China
- National Natural Science Foundation of China